Clinical Trials Browser

Phase 1 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Clear all

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell

NCT03991884 2023-07-06

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Phase 1 Completed

24 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT01786135 2017-10-19

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Phase 1 Completed

64 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Follicular, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT01786096 2017-07-02

A Safety Study of SGN-CD19A for Leukemia and Lymphoma

Phase 1 Completed

92 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

FT819 in Subjects With B-cell Malignancies

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

A Safety Study of SGN-CD19A for B-Cell Lymphoma

A Safety Study of SGN-CD19A for Leukemia and Lymphoma